Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Identifying safe long term investments is essential for risk-averse investors. Learn about reliable options to secure your financial future.
26,844 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Micron Technology is at a pivotal moment as AI-related demand collides with a cyclical memory market. Shares have sur...
Hims & Hers beat quarterly EPS but trimmed full-year guidance, extending a slide in its stock as regulatory headwinds...
Inflation isn’t just a headline—it's a real market force that tests how consumers spend on discretionary goods. Explo...
Lucid Group delivered a stronger top line in Q4, but cash burn remains a key hurdle. Investors will parse the mix of ...
Oil prices hovered in the mid-$80s on June 15, 2026, as traders weighed supply-demand signals and geopolitical develo...
Dell Technologies delivers a blowout quarter, driven by a 73% jump in Infrastructure Solutions revenue to $19.6 billi...
Savers face a rate tug-of-war in 2026 as money market accounts high yields compete with high yield savings accounts. ...
Is Nike losing its spark in performance running? This article dives into whether nike lost edge performance and what ...
Chipmakers retreat after Samsung delivers mixed earnings, triggering a broader sector reset. Intel and Applied Materi...
IGV climbed roughly 5% over the past week, defying a broader tech pullback. Yet traders remain split on whether the A...
Rambus rides AI infrastructure tailwinds but keeps a neutral stance as investors weigh valuation against accelerating...